The New Zealand Commerce Commission has published a Statement of Issues concerning Zoetis Holdings LLC's application to acquire the global animal genomic testing business of Neogen Corporation. This document outlines the Commission's preliminary competition concerns following an initial investigation into the merger.

It is important to note that the Statement of Issues does not represent a final decision; it merely indicates that the Commission has identified potential issues that need to be addressed. The Commission is actively seeking submissions from Zoetis, Neogen, and other interested parties regarding the concerns raised.

Submissions can be sent via email to the Commission, with a deadline set for close of business on 10 August 2026. Additionally, cross-submissions are due by 18 August 2026. The Commission aims to make a decision on the merger application by 15 September 2026, although this date may be extended if necessary.

The Commission's clearance for a proposed merger hinges on its assessment that the merger will not substantially lessen competition in the relevant market. Further information on the merger assessment process is available from the Commission.